🔎 Our study finds that 13.5% of men initially eugonadal showed tT levels suggestive of TD at 3-month follow-up. These men had reduced baseline testicular volume and abnormal karyotype. doi.org/10.5534/wjmh.2… Edoardo Pozzi Christian Corsini Massimiliano Raffo Luca Boeri M.D. ScrittoreSalonia

Another great talk - Edoardo Pozzi Nutraceuticals seem effective in combination with PDE5Is e.g. L-arginine for ED. Sounds like the Wild West though, issues with regulation #ESSM2025

Age-related decline in total testosterone levels among young men: insights from a large single-center observational study | International Journal of Impotence Research nature.com/articles/s4144…

Age-related decline in total #testosterone levels among young men: insights from a large study 👉nature.com/articles/s4144… Christian Corsini Edoardo Pozzi Ospedale San Raffaele Federico Belladelli Fausto Negri Massimiliano Raffo Luca Boeri M.D. Eugenio Ventimiglia Luigi Candela Francesco Montorsi Andrea Salonia, MD. PhD

The February 2025 Issue of IJIR has been just released. Check it out 👉nature.com/ijir/volumes/3… Vaibhav Modgil | Urological Surgeon & Andrologist Peter Grice raj mathur Ian Pearce Prasad Kole Akula Matthias Hofer UT Health San Antonio Nuno Tomada Universidade Porto Patrícia M. Pascoal Alice Xiang Chrystal Chang, MD Daniel Swerdloff Jay Simhan, MD UCSFUrology

congratulations to omer onur cakir for his great guideline changing editorial King's College London King's Fertility KCH_Urology edoardo pozzi Ospedale San Raffaele BMJ Oncology Fabio Castiglione

💊🔬 First study ever: Testosterone therapy in men with TD & family history of prostate cancer (high-risk) shows NO increased cancer risk over 10 years compared to matched untreated men! Link 🔗:bmjoncology.bmj.com/content/4/1/e0… BMJ Oncology Corey Able, MD Taylor P Kohn ScrittoreSalonia

Men with testosterone deficiency and a family history of prostate cancer did not have a significantly higher risk of being diagnosed with cancer from receiving testosterone therapy. bmjoncology.bmj.com/content/4/1/e0…

Testosterone therapy represents a cornerstone in the management of testosterone deficiency, yet its use in men at high risk for prostate cancer has remained controversial. bmjoncology.bmj.com/content/4/1/e0…

💡 Stay ahead in Von Hippel-Lindau (VHL) management! Join our new #UROwebinar, which offers essential updates on current standards, innovations, and practical decision-making across specialties. Register now and claim your CME credit 👇 webinars.uroweb.org/EAU/webinars/1… Alessandro Larcher

✅Great collaborative work: men with testicular cancer who choose a testicular prosthesis during surgery experience significantly ⬇️ regret + better body image + ⬆️ satisfaction than those who choose not to have it 🔗 Link: sciencedirect.com/science/articl… Luca Boeri M.D.

🤝 Meet the ESSM Basic Science Committee – driving innovation in #SexualMedicine! 🧬 They promote research, develop content for Congresses & webinars, and bridge benchside science with clinical care. 📲Swipe up to meet the team. omer onur cakir

Comment on: Male sexual dysfunction associated with GLP-1 receptor agonists: a cross-sectional analysis of FAERS data 👉 rdcu.be/ewVP1 Edoardo Pozzi Andrea Salonia, MD. PhD Università Vita-Salute San Raffaele

Men with #DelayedEjaculation report lower sexual satisfaction and more depressive symptoms than those with #PrematureEjaculation 👉 rdcu.be/exOvK Fausto Negri Christian Corsini Edoardo Pozzi Massimiliano Raffo Luca Boeri M.D. Francesco Montorsi Michael Eisenberg Andrea Salonia, MD. PhD Ospedale San Raffaele

🌍📈🧬 #Epidemiology of #RenalCancer: #Incidence, #Mortality, #Survival, #GeneticPredisposition, and #RiskFactors authors.elsevier.com/a/1lX0v14kpm0h… Up-to -date facts and figures together with future projections at European Urology

#Azoospermia #microTESE #Pub2Post tnyp.me/dbkMaqkS